Cytosorbents Corporation
CTSO
$1.13
$0.032.73%
Weiss Ratings | CTSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E | |||
Rating Factors | CTSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Very Weak | |||
Solvency Index | Good | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | CTSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.97 | |||
Price History | CTSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 11.88% | |||
30-Day Total Return | 13.00% | |||
60-Day Total Return | 39.49% | |||
90-Day Total Return | 29.81% | |||
Year to Date Total Return | 22.83% | |||
1-Year Total Return | 16.97% | |||
2-Year Total Return | -64.91% | |||
3-Year Total Return | -66.07% | |||
5-Year Total Return | -72.84% | |||
52-Week High % Change | -29.81% | |||
52-Week Low % Change | 61.43% | |||
Price | CTSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $1.61 | |||
52-Week Low Price | $0.70 | |||
52-Week Low Price (Date) | Jul 01, 2024 | |||
52-Week High Price (Date) | Feb 14, 2025 | |||
Valuation | CTSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 61.79M | |||
Enterprise Value | 82.91M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.36 | |||
Earnings Per Share Growth | -32.05% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 1.63 | |||
Price/Book (Q) | 4.74 | |||
Enterprise Value/Revenue (TTM) | 2.20 | |||
Price | $1.13 | |||
Enterprise Value/EBITDA (TTM) | -4.19 | |||
Enterprise Value/EBIT | -3.88 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | CTSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 54.45M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | CTSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 732 329 8885 | |||
Address | 305 College Road East Princeton, NJ 08540 | |||
Website | www.cytosorbents.com | |||
Country | United States | |||
Year Founded | 1997 | |||
Profitability | CTSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -56.63% | |||
Profit Margin | -49.47% | |||
Management Effectiveness | CTSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -28.01% | |||
Return on Equity | -- | |||
Income Statement | CTSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 37.74M | |||
Total Revenue (TTM) | 37.74M | |||
Revenue Per Share | $0.69 | |||
Gross Profit (TTM) | 23.67M | |||
EBITDA (TTM) | -19.80M | |||
EBIT (TTM) | -21.37M | |||
Net Income (TTM) | -18.67M | |||
Net Income Avl. to Common (TTM) | -18.67M | |||
Total Revenue Growth (Q YOY) | 6.58% | |||
Earnings Growth (Q YOY) | 74.61% | |||
EPS Diluted (TTM) | -0.36 | |||
EPS Diluted Growth (Q YOY) | 79.30% | |||
Balance Sheet | CTSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 5.69M | |||
Cash Per Share (Q) | $0.10 | |||
Total Current Assets (Q) | 16.60M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 13.00M | |||
Current Ratio (Q) | 1.969 | |||
Book Value Per Share (Q) | $0.24 | |||
Total Assets (Q) | 47.80M | |||
Total Current Liabilities (Q) | 8.43M | |||
Total Debt (Q) | 26.81M | |||
Total Liabilities (Q) | 34.80M | |||
Total Common Equity (Q) | 13.00M | |||
Cash Flow | CTSO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -681.20K | |||
Cash from Financing (TTM) | 21.37M | |||
Net Change in Cash (TTM) | 2.12M | |||
Levered Free Cash Flow (TTM) | -11.70M | |||
Cash from Operations (TTM) | -18.49M | |||